Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Other Non Operating Income (2019 - 2024)

Historic Other Non Operating Income for AdaptHealth (AHCO) over the last 6 years, with Q4 2024 value amounting to $552000.0.

  • AdaptHealth's Other Non Operating Income rose 10240.08% to $552000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $552000.0, marking a year-over-year increase of 10192.94%. This contributed to the annual value of -$2.8 million for FY2024, which is 9055.33% up from last year.
  • AdaptHealth's Other Non Operating Income amounted to $552000.0 in Q4 2024, which was up 10240.08% from -$2.3 million recorded in Q3 2024.
  • AdaptHealth's Other Non Operating Income's 5-year high stood at $6.9 million during Q4 2022, with a 5-year trough of -$23.0 million in Q4 2023.
  • For the 5-year period, AdaptHealth's Other Non Operating Income averaged around -$3.2 million, with its median value being -$2.2 million (2023).
  • As far as peak fluctuations go, AdaptHealth's Other Non Operating Income soared by 19945654.1% in 2020, and later crashed by 119066.15% in 2023.
  • Quarter analysis of 5 years shows AdaptHealth's Other Non Operating Income stood at -$5.3 million in 2020, then tumbled by 55.0% to -$8.2 million in 2021, then skyrocketed by 184.05% to $6.9 million in 2022, then crashed by 431.97% to -$23.0 million in 2023, then surged by 102.4% to $552000.0 in 2024.
  • Its last three reported values are $552000.0 in Q4 2024, -$2.3 million for Q3 2024, and $1.8 million during Q2 2024.